Search results (3143)
« Back to PublicationsThe CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.
Kazungu Y. et al, (2026), Virulence, 17
Cellular immunity to Streptococcus pneumoniae: implications for vaccine-mediated prevention.
VanSeggelen H. et al, (2026), Expert Rev Vaccines, 25
Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.
Monk V. et al, (2026), Expert Rev Vaccines, 25
Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.
Firth C. et al, (2026), Hum Vaccin Immunother, 22
What is unhealthy about public health? Vaccination, evidence and the politics of uncertainty
Mezza M. and Vanderslott S., (2026), Humanities and Social Sciences Communications, 13
High respiratory syncytial virus burden in children under 3 years of age across all care levels in England.
Carter EC. et al, (2026), BMJ Open Respir Res, 13
Differential ChAdOx1 and ChAdOx2 transduction efficiency and receptor specificity in human and mouse B cell lines in vitro.
Nazki S. et al, (2026), Virology, 624
Measles in Ugandan Children Under 18 Months of Age: A Retrospective Study of Case-based Surveillance, 2018-2024.
Businge GB. et al, (2026), Open Forum Infect Dis, 13
COVID-19 vaccine effectiveness and SARS-CoV-2 variants in Nepal: Test-negative case-control study and genetic sequencing (COVVAR Nepal)
Pokhrel B. et al, (2026), Vaccine X, 31
ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.
Ebrahimi N. et al, (2026), Vaccine, 88
Genome-wide association study of susceptibility to pneumococcal carriage amongst children
Kandasamy R. et al, (2026)